Nurix Therapeutics, Inc.
NRIX
DELAYED 1 MONTH
18 insider filings · Latest: Jul 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 30 9:58 PM | Hans Van HouteChief Financial Officer | Sale | 2,845 | $23.38 | $66.5K | 44,927(D) | View → |
| Jul 30, 2026 | Jul 30 9:56 PM | Christine RingChief Legal Officer | Sale | 3,847 | $23.38 | $90.0K | 19,912(D) | View → |
| Jul 30, 2026 | Jul 30 9:50 PM | Gwenn HansenChief Scientific Officer | Sale | 3,847 | $23.38 | $90.0K | 121,338(D) | View → |
| Jun 2, 2026 | Jun 2 11:14 PM | Christine RingChief Legal Officer | Sale | 8,148 | $16.60 | $135.3K | 13,579(D) | View → |
| May 5, 2026 | May 5 11:53 PM | Houte Hans VanChief Financial Officer | Sale | 14,055 | $16.60 | $233.3K | 37,592(D) | View → |
| May 4, 2026 | May 4 10:10 PM | Christine RingChief Legal Officer | Sale | 8,148 | $16.96 | $138.2K | 18,305(D) | View → |
| May 1, 2026 | May 1 9:50 PM | Christine RingChief Legal Officer | Sale | 5,394 | $16.76 | $90.4K | 26,453(D) | View → |
| Apr 30, 2026 | Apr 30 9:38 PM | Houte Hans VanChief Financial Officer | Sale | 2,388 | $16.65 | $39.7K | 51,647(D) | View → |
| Apr 30, 2026 | Apr 30 9:37 PM | Christine RingChief Legal Officer | Sale | 3,214 | $16.65 | $53.5K | 31,847(D) | View → |
| Apr 30, 2026 | Apr 30 9:35 PM | Gwenn HansenChief Scientific Officer | Sale | 3,214 | $16.65 | $53.5K | 120,399(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 30 9:58 PM | Hans Van HouteChief Financial Officer | Option Exercise | 10,180 | — | 39,303(D) | View → |
| Jul 30, 2026 | Jul 30 9:56 PM | Christine RingChief Legal Officer | Option Exercise | 10,180 | — | 39,303(D) | View → |
| Jul 30, 2026 | Jul 30 9:50 PM | Gwenn HansenChief Scientific Officer | Option Exercise | 10,180 | — | 39,303(D) | View → |
| Jun 2, 2026 | Jun 2 11:14 PM | Christine RingChief Legal Officer | Option Exercise | 3,422 | $1.86 | 5,221(D) | View → |
| May 15, 2026 | May 15 9:56 PM | Paul M SilvaDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:55 PM | Edward C SaltzmanDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:52 PM | Judith A ReinsdorfDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:51 PM | David L. LaceyDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:49 PM | Anil KapurDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:46 PM | Roger D DanseyDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:42 PM | Roy D. BaynesDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| May 15, 2026 | May 15 9:37 PM | Julia P GregoryDirector | Grant/Award | 31,250 | $15.86 | 31,250(D) | View → |
| Apr 30, 2026 | Apr 30 9:38 PM | Houte Hans VanChief Financial Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:37 PM | Christine RingChief Legal Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |
| Apr 30, 2026 | Apr 30 9:35 PM | Gwenn HansenChief Scientific Officer | Option Exercise | 8,608 | — | 22,867(D) | View → |